Mimedx (MDXG) Retained Earnings (2010 - 2026)

Mimedx has disclosed Retained Earnings across 17 years of filings, most recently posting -$53.5 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$53.5 million, up 36.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$53.5 million (up 36.44% YoY), and the FY2025 annual result was -$42.7 million, up 53.23% from the prior year.
• Retained Earnings came in at -$53.5 million for Q1 2026 at Mimedx, down from -$42.7 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$42.7 million in Q4 2025 to a low of -$196.9 million in Q1 2023.
• The 5-year median for Retained Earnings is -$124.4 million (2024), against an average of -$128.6 million.
• Across the five-year window, Retained Earnings dropped 18.67% in 2022 and surged 53.23% in 2025, its largest moves.
• Mimedx's Retained Earnings stood at -$191.9 million in 2022, then surged by 30.34% to -$133.7 million in 2023, then soared by 31.73% to -$91.3 million in 2024, then soared by 53.23% to -$42.7 million in 2025, then fell by 25.44% to -$53.5 million in 2026.
• The last three Retained Earnings figures came in at -$53.5 million (Q1 2026), -$42.7 million (Q4 2025), and -$57.9 million (Q3 2025), per Business Quant data.